Fall Clinical Dermatology 2025 -
![](https://dermsquared.org/_next/image?url=https%3A%2F%2Fd18uhdhjoz8by6.cloudfront.net%2Flarge_Entry_at_Dusk_4892df2365.jpg&w=3840&q=75)
![](https://dermsquared.org/_next/image?url=https%3A%2F%2Fd18uhdhjoz8by6.cloudfront.net%2Flarge_scott_webb_Wng_El_D_Na9qs_unsplash_13ddebea5c.jpg&w=3840&q=75)
![](https://dermsquared.org/_next/image?url=https%3A%2F%2Fd18uhdhjoz8by6.cloudfront.net%2Fwynn_las_vegas_b88bba574c.png&w=3840&q=75)
Fall Clinical Dermatology 2025 – Almirall, a leading biopharmaceutical company specializing in medical dermatology, has reported its full-year 2025 financial results, showcasing . Presenter: Dr. Mark S. Nestor, M.D., Ph.D., Voluntary Professor, Department of Dermatology and Cutaneous Surgery, Department of Surgery, Division of Plastic Surgery, University of Miami, Miller School .
![](https://dermatologyauthority.com/wp-content/uploads/2023/06/Screenshot-2023-06-21-at-5.24.48-PM.png)
![](https://d18uhdhjoz8by6.cloudfront.net/Green_Minimalist_Financial_Services_Table_Graph_3_ac4b081ddd.png)
Fall Clinical Dermatology 2025 Fall Clinical: Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces its sponsorship of the Fall Clinical Dermatology Conference . Taylor Endowed Professor of Clinical Dermatology at U-M Medical School. Experts observed in a new study that injection of the most popular type of dermal filler, cross-linked hyaluronic acid .
![](https://d18uhdhjoz8by6.cloudfront.net/IMG_2339_07a6ec7899.jpg)